SFX by Ex Libris Inc.

Title:	Murine Leukemia Induced by Retroviral Gene Marking
Source:	Science [0036-8075] Li, Zhixiong yr:2002

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hacien-Bey-Abina, S. "LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 (vol 302, pg 415, 2003)." Science 302.5645 (2003): 568-568.
description	2.	Hacein-Bey-Abina, S. "LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1." Science 302.5644 (2003): 415-9.
description	3.	Adriaansen, J. "Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: Innovative vectors and therapeutic genes." Rheumatology 45.6 (2006): 656-668.
description	4.	Dave, Utpal P P. "Gene Therapy Insertional Mutagenesis Insights." Science 303.5656 (2004): 333-333.
description	5.	Vallera, DA. "Retroviral Immunotoxin Gene Therapy of Leukemia in Mice Using Leukemia-Specific T Cells Transduced with an Interleukin-3/Bax Fusion Protein Gene." Human gene therapy 14.18: 1787-1798.
description	6.	Calvo, M. "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease." Science 288.5466 (2000): 669-672.
description	7.	Cavazzana-Calvo, M. "Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1." The journal of clinical investigation 118.9 (2008): 3132-42.
description	8.	Hacein-Bey-Abina, S. "Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy." New England Journal of Medicine, The 346.16 (2002): 1185-1193.
description	9.	Baum, C. "Chance or necessity? Insertional mutagenesis in gene therapy and its consequences." Molecular therapy 9.1 (2004): 5-13.
description	10.	Rabbitts, Terence H H. "Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency." The New England journal of medicine 350.9 (2004): 913-22.
description	11.	Tiberghien, P. "Improving the ex vivo retroviral-mediated suicide-gene transfer process in T lymphocytes to preserve immune function." Cytotherapy 7.2: 150-7.
description	12.	Ledley, F D D. "Nonviral gene therapy: the promise of genes as pharmaceutical products." Human gene therapy 6.9 (1995): 1129-44.
description	13.	Vervoordeldonk, M. "Gene therapy in rheumatic diseases." Baillière's best practice & research. Clinical rheumatology 15.5 (2001): 771-788.
description	14.	Cavazzana-Calvo, M. "The future of gene therapy." Nature 427.6977 (2004): 779-781.
description	15.	Woods, Niels-Bjarne B. "Gene therapy: therapeutic gene causing lymphoma." Nature 440.7088: 1123-1123.
description	16.	Yi, Y. "Current advances in retroviral gene therapy." Current gene therapy 11.3 (2011): 218-28.
description	17.	Segel, MJ. "Effect of IL-2-Bax, a novel interleukin-2-receptor-targeted chimeric protein, on bleomycin lung injury 1." International journal of experimental pathology (2005): 279-.
description	18.	Thomas, Clare E E. "Progress and problems with the use of viral vectors for gene therapy." Nature reviews. Genetics 4.5 (2003): 346-58.
description	19.	Tak, Paul P P. "Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5." Human gene therapy 17.8 (2006): 821-32.
description	20.	Tak, P P P. "The role of chemokines in rheumatoid arthritis and osteoarthritis." Scandinavian journal of rheumatology 34.6 (2005): 415-25.